Protagenic Therapeutics I... (PTIX)
NASDAQ: PTIX
· Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT
Protagenic Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 872.96K | 1.84M | 1.06M | 924.6K | 831.78K | 1.29M | 153.33K | 219.44K | 138.49K | 215.19K | 158.32K | 338.67K | 482.18K | 541.17K | 460.12K | 11.93M | 191.67K |
Short-Term Investments | n/a | n/a | n/a | n/a | 1.59M | 2.77M | 5.12M | 5.82M | 7.51M | 7.76M | 7.99M | 8.53M | 9.3M | 9.83M | 10.39M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 928.18K | 1.88M | 1.42M | 1.37M | 2.47M | 4.2M | 5.38M | 6.92M | 7.66M | 8.04M | 8.25M | 9.01M | 9.8M | 11.06M | 11.66M | 12.06M | 196.14K |
Property-Plant & Equipment | 60.47K | 73.05K | 85.62K | 98.19K | 110.76K | 123.33K | 55.98K | 1.59K | 1.69K | 1.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 60.47K | 73.05K | 85.62K | 98.19K | 110.76K | 123.33K | 55.98K | 1.59K | 1.69K | 1.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 988.65K | 1.96M | 1.51M | 1.47M | 2.58M | 4.32M | 5.43M | 6.92M | 7.67M | 8.04M | 8.25M | 9.01M | 9.8M | 11.06M | 11.66M | 12.06M | 196.14K |
Account Payables | 165.25K | 102.96K | 108.64K | 93.46K | 108.95K | 113.8K | 243.52K | 158.17K | 174.87K | 155.49K | 139.34K | 334.3K | 279.29K | 278.96K | 273.64K | 184.72K | 233.75K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 419.76K | 394.31K | 369.13K | 344.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.08M | 942.76K | 789.32K | 674.56K | 446.1K | 655.25K | 1.28M | 1.51M | 1.25M | 1.12M | 553.48K | 463.09K | 783.64K | 799.53K | 724.42K | 602.59K | 650.97K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 318.78K | 293.32K | 295.06K | 318.43K | 562.09K | 661.41K | 1.53M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.01M | 318.78K | 293.32K | 295.06K | 318.43K | 562.09K | 661.41K | 1.53M |
Total Liabilities | 1.08M | 942.76K | 789.32K | 674.56K | 446.1K | 655.25K | 1.28M | 1.51M | 1.25M | 1.12M | 872.26K | 756.41K | 1.08M | 1.12M | 1.29M | 1.26M | 2.18M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | 419.76K | 394.31K | 369.13K | 344.23K | 318.78K | 293.32K | 295.06K | 318.43K | 562.09K | 661.41K | 1.53M |
Common Stock | 54.00 | 725.00 | 481.00 | 447.00 | 444.00 | 444.00 | 434.00 | 434.00 | 434.00 | 434.00 | 1.73K | 1.73K | 1.73K | 1.72K | 1.7K | 1.63K | 1.06K |
Retained Earnings | -37.74M | -36.3M | -34.75M | -34.11M | -32.5M | -30.78M | -29.1M | -27.71M | -26.5M | -25.78M | -25.18M | -24.25M | -23.58M | -22.22M | -21.33M | -20.45M | -18.91M |
Comprehensive Income | -129.86K | -129.85K | -130.25K | -130.16K | -86.77K | -113.55K | -617.74K | -586.46K | -628.76K | -676.91K | -615.11K | -449.68K | -399.36K | -248.35K | -172.38K | -170.61K | -171.09K |
Shareholders Equity | -88.33K | 1.01M | 719.01K | 792.52K | 2.13M | 3.67M | 4.15M | 5.41M | 6.41M | 6.92M | 7.38M | 8.26M | 8.72M | 9.94M | 10.37M | 10.8M | -1.98M |
Total Investments | n/a | n/a | n/a | n/a | 1.59M | 2.77M | 5.12M | 5.82M | 7.51M | 7.76M | 7.99M | 8.53M | 9.3M | 9.83M | 10.39M | n/a | n/a |